GlassScriptPhysician profile
Dennis Wayne Simpson
NPI 1467989053
$1,469.79
in general payments reported to CMS, 2019-2025
16 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $125 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394 · Education: $75.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.29 |
| Education | $75.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $435.32 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $368.07 | 2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $127.31 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $89.65 | 2024-2025 | Cobenfy |
| Alkermes, INC. | $79.90 | 2025 | Aristada, Lybalvi, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $75.50 | 2025 | |
| Glaxosmithkline, LLC. | $64.82 | 2025 | Trelegy Ellipta |
| Lundbeck LLC | $50.39 | 2025 | Rexulti |
| Indivior INC. | $36.32 | 2025 | Sublocade |
| Lilly USA, LLC | $29.38 | 2024-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $23.12 | 2024 | Invega Sustenna |
| Axsome Therapeutics, INC. | $20.53 | 2025 | Auvelity |
| Corcept Therapeutics | $19.81 | 2025 | Korlym |
| Regeneron Healthcare Solutions, INC. | $18.59 | 2025 | Evkeeza |
| Novo Nordisk INC | $16.84 | 2025 | Rybelsus, Ozempic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.24 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.